6/24/2021NMPA Revises Packages Insert of Oxiracetam Formulations and Injectable...

6/23/2021Online Platform Operator Medlive Tech Advances Plans for Hong Kong IPO

6/23/2021HUTCHMED's Orpathys Conditionally Approved in China for NSCLC

6/23/2021Innovent's Sintilimab in Combo with Chemotherapy Meets Primary Endpoin...

6/22/2021Innovent's Pemazyre (pemigatinib) Approved in Taiwan

6/22/2021Hutchmed Granted Chinese Approval of Surufatinib (Sulanda) for Advance...

6/22/2021China NMPA Approves Tislelizumab in Non-Small Cell Lung Cancer and Hep...

6/21/2021AZ/MSD Granted New Indication for Lynparza (olaparib) in China

6/21/2021China and U.K. Initiate Drug Regulatory Cooperation Project

6/18/2021NHSA Announces Outcome of Its Inventory Survey for Drugs Included in t...

6/18/2021Harbour BioMed and Dana-Farber Cancer Institute Collaborate to Advance...

6/18/2021Recent Executive Moves

6/18/2021PharmaDJ's China Licensing Deals Tracker: April 2021

6/17/2021Can-Fite Receives Notice of Patent Allowance in China for NASH Treatme...

6/17/2021MacroGenics and Zai Lab Enter into Broad Strategic Deal for Preclinica...

6/17/2021Sirnaomics Announces NMPA IND Acceptance for Global Multicenter Phase ...

6/17/2021Roche Secures Chinese Approval of Evrysdi (Risdiplam) under Priority R...

6/17/2021State Council Issues Document on Major Tasks of Healthcare Reform in 2...

6/16/2021140 Low-Cost Supplementary Medical Insurance Plans Launched in 26 Prov...

6/16/2021NMPA Announces Package Insert Revision of Carbimazole Tablets

6/15/2021USFDA Approved IND to Investigate Combo of Asieris' APL-1202 and BeiGe...

6/15/2021Over 6M People in Shanghai Enroll in Low-Cost Supplementary Health Ins...

6/15/2021NHSA Publishes 2020 National BMI Sector Development Report

6/15/2021NHSA Solicits Comments on the Healthcare Security Law of PRC

6/15/2021NMPA and Chinese Customs Announce Addition of Changchun Airport as a D...

6/14/2021AiPharma Signs Production and Distribution Deal for China and Russia w...

6/14/2021I-Mab in Talks for a $Billion Deal for Cancer Therapy: Bloomberg

6/11/2021Recent Executive Moves

6/11/2021China Imposes $117M Fine for Resale Price Maintenance for the First T...

6/10/2021PharmaDJ's China Market Approval Tracker: April 2021

Page:102/371 Total number of articles:11107: [First][<<] [100] [101] [102] [103] [104] [>>] [End]